Bsx stock price increased to $74

BSX stock price increased to $74.05 amid broader Nasdaq healthcare index gains. This supports sentiment that large-cap medical device makers are positioned for robust 2024 earnings growth. The upcoming earnings release of Boston Scientific will be of great interest to investors. The company's earnings report is expected on October 22, 2025. It is anticipated that the company will report an EPS of $0.71, marking a 12.7% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $4.95 billion, indicating a 17.69% upward movement from the same quarter last year. Boston Scientific has demonstrated considerable revenue growth in recent years. Over the last three years, its top line has expanded at an average rate of 13.1%, significantly outperforming the S&P 500’s 5.5% increase. More recently, Boston Scientific’s revenues grew by 19.4% over the last twelve months, increasing from $15 billion to $18 billion. In its most recent quarter, quarterly revenues saw a robust 20.9% rise, reaching $4.7 billion from $3.9 billion a year ago. These figures underscore the company’s strong operational momentum in driving sales. BSX stock price reached $73.40, navigating volatile sentiment tied to Fed interest rate signals. Institutional investors have been increasing holdings, suggesting confidence in Boston Scientific’s innovation pipeline and market share gains.